Contribute Try STAT+ Today

Editor’s note: A previous version of this story stated incorrectly that Deborah Celeste Kelly, the wife of CytoDyn chairman Scott Kelly, had sold $2.6 million in company stock. Deborah Kelly filed an intention to sell company stock with the Securities and Exchange Commission.

The wife of CytoDyn’s chairman disclosed an intent to sell company stock worth $2.6 million as CytoDyn prepares to disclose results of a long-delayed clinical trial involving a treatment for patients with severe Covid-19. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Why get so emotional about it? The randomized “Phase II” study was done in only 86 patients, hardly enough to come to a conclusion. CytoDyn needs postive results in there much larger phase III study.

    • If you don’t get emotional over excess COVID deaths then I don’t know what to say. Adam has continually lied about the results of the Phase II study which did show in a statistically significant way that drug patients were twice as likely as placebo to benefit from treatment (pvalue 0.0223).

      Adam is a coward who has removed the ability for people to respond to his tweets. And he is likely being paid as a shill for Big Pharma and perhaps also some of these lying short sellers. There is blood on his hands for his actions and he should answer for his lies.

  • How does it feel not to have any influence or credibility, Adam? People are starting to realize that you’re in Big Pharma’s back pocket and that your “opinions” are paid for.

    Why must you lie about CytoDyn? You know full well that their moderate study produced a statistically significant endpoint and yet you lie and say that it didn’t. There is a special place in hell for people like you–people who publish lies and misleading information about companies working toward a COVID therapeutic. Your lies are costing lives.

Comments are closed.